Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
CompletedNot applicableNCT00127413
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to examine the efficacy of an integrated treatment for Veterans with comorbid chronic pain and posttraumatic stress disorder (PTSD). It is hypothesized that Veterans who receive the integrated treatment will report more positive outcomes than individuals who are assigned to treatment as usual, pain treatment, or PTSD treatment.
Study details
- Official title
- Integrated Treatment for Chronic Pain and PTSD
- Conditions
- Interventions
- Behavioral: Cognitive Behavioral Therapy - Pain
- Behavioral: Cognitive Behavioral Therapy-Integrated
- Behavioral: Cognitive Processing Therapy - PTSD
- Behavioral: Treat as Usual
- Sponsor
- US Department of Veterans Affairs
- Organization
- VA Office of Research and Development
- Start date
- 2004-09
- Primary completion
- 2010-09
- Sex
- All
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients will be eligible for participation if they have chronic pain, defined as constant pain of at least six months duration with a neurologic or musculoskeletal etiology. Patients must also meet criteria for PTSD. * Stability of pain and anxiety medications will be required for two months prior to study entry and during the active treatment and TAU phase. Exclusion Criteria: * Patients with life threatening or acute physical illness (e.g., cancer). * Current alcohol or substance abuse or dependence. Veterans who have a history of alcohol or drug dependence but who have not had problematic use in the last six months will be included in the study. * Current psychosis or suicidal ideation. * Individuals seeking pain treatment such as surgical interventions will be excluded.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00127413